Stock BIE BIOERA S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bioera S.p.A.

Equities

BIE

IT0005516130

Food Processing

Market Closed - Borsa Italiana
Other stock markets
 11:44:59 2024-04-26 am EDT 		5-day change 1st Jan Change
0.089 EUR -0.45% Intraday chart for Bioera S.p.A. +32.84% +66.36%
2023 Bioera S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 Bioera S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 7.052 2.608 3.778 2.416 3.059 1.318
Enterprise Value (EV) 1 18.1 12.26 15.55 15.18 10.68 4.323
P/E ratio -1.31 x -0.72 x -0.59 x -0.83 x -10.2 x -0.34 x
Yield - - - - - -
Capitalization / Revenue 0.15 x 0.06 x 0.12 x 0.22 x 2.67 x 2.28 x
EV / Revenue 0.39 x 0.3 x 0.51 x 1.37 x 9.33 x 7.48 x
EV / EBITDA -5.41 x -8.56 x -3.95 x -3.73 x -4.2 x -1.35 x
EV / FCF -11.4 x 12 x 4.32 x -79.9 x -1.88 x -28 x
FCF Yield -8.74% 8.34% 23.2% -1.25% -53.1% -3.57%
Price to Book 1 x 0.57 x -0.45 x -0.28 x -2.42 x -0.26 x
Nbr of stocks (in thousands) 385 454 569 869 3,013 3,069
Reference price 2 18.33 5.740 6.639 2.780 1.015 0.4295
Announcement Date 4/30/18 4/30/19 5/4/20 4/30/21 4/30/22 5/15/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 46.19 40.23 30.74 11.06 1.145 0.578
EBITDA 1 -3.346 -1.433 -3.935 -4.065 -2.542 -3.199
EBIT 1 -4.177 -1.976 -4.975 -4.24 -2.619 -3.211
Operating Margin -9.04% -4.91% -16.18% -38.35% -228.73% -555.54%
Earnings before Tax (EBT) 1 -5.933 -3.397 -7.528 -7.132 15.35 -4.09
Net income 1 -5.146 -3.631 -5.966 -2.953 -0.202 -3.987
Net margin -11.14% -9.03% -19.41% -26.71% -17.64% -689.79%
EPS 2 -13.98 -7.989 -11.16 -3.366 -0.1000 -1.272
Free Cash Flow 1 -1.582 1.023 3.602 -0.19 -5.672 -0.1542
FCF margin -3.43% 2.54% 11.72% -1.72% -495.33% -26.69%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/30/18 4/30/19 5/4/20 4/30/21 4/30/22 5/15/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 11 9.66 11.8 12.8 7.62 3.01
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -3.302 x -6.738 x -2.992 x -3.14 x -2.998 x -0.9394 x
Free Cash Flow 1 -1.58 1.02 3.6 -0.19 -5.67 -0.15
ROE (net income / shareholders' equity) -86.9% -109% 374% 81.7% -384% 268%
ROA (Net income/ Total Assets) -6.94% -3.87% -12.1% -13.9% -9.9% -20.8%
Assets 1 74.13 93.93 49.21 21.32 2.04 19.12
Book Value Per Share 2 18.40 10.10 -14.80 -9.770 -0.4200 -1.630
Cash Flow per Share 2 1.540 1.060 0.3400 0.1200 0.0100 0.0100
Capex 1 0.65 0.46 0.02 - 0.06 -
Capex / Sales 1.4% 1.15% 0.05% - 5.59% -
Announcement Date 4/30/18 4/30/19 5/4/20 4/30/21 4/30/22 5/15/23
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
BIOERA S.P.A. Stock Bioera S.p.A.
+66.36% 1.81M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+8.20% 7.78B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+1.64% 7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+10.20% 6.52B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-8.10% 3.67B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-14.57% 1.17B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+8.34% 934M
HERBALIFE LTD. Stock Herbalife Ltd.
-42.27% 879M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-18.90% 836M
JAMIESON WELLNESS INC. Stock Jamieson Wellness Inc.
-16.45% 802M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. BIE Stock
  4. Financials Bioera S.p.A.